SNORD17 can promote the methylation of KAT6B mRNA, leading to decreased KAT6B expression, which in turn promotes the upregulation of VEGFR2 and VE-cadherin expression, thereby facilitating VM in GBM (125). The gene discussed is KAT6B; the disease is glioblastoma.